WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) announces plenary sessions, Business Roundtables and Therapeutic Workshops selected for the 14th Annual BIO CEO & Investor Conference. Experts chosen to speak on these panels represent leading clinical practitioners, investment professionals, industry analysts and senior biotechnology executives. The conference, to be held February 13-14, 2012 in New York City, is the largest independent investor conference focused on established and publicly-traded biotechnology companies.
